- Telehealth visits
- Insurance plan information
Tim Ferng, MD
Hematology and Medical Oncology • Medical Oncology- Telehealth visits
- Insurance plan information
Tim Ferng, MD
Hematology and Medical Oncology • Medical Oncology- Telehealth visits
- Insurance plan information
On this page
Education & training
Board certification
- Hematology, American Board of Internal Medicine/Hematology
- Medical Oncology, American Board of Internal Med/Medical Oncology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hematology - Oncology, UCSF School of Medicine -GME
Residency
- Internal Medicine, New York Presbyterian Hospital - Weill Cornell
Internship
- Internal Medicine, New York Presbyterian Hospital - Weill Cornell
Degree
- MD, Wayne State University School of Medicine
Academic title
- Health Sciences Clinical Professor
My expertise
Locations
My research
Clinical trials
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)Opens in a new window
Recruiting
An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the phar...Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaOpens in a new window
Recruiting
Assessed by the NCI-CTCAE v5.0MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Opens in a new window
Recruiting
Will evaluate the feasibility of MATCHBox generating all data needed for assignment to a myeloMATCH clinical trial or determination that no assignment is avail...Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)Opens in a new window
Recruiting
Will assess after one induction cycle with or without the addition of venetoclax or two cycles of venetoclax and azacitidine. MRD by flow cytometry will be con...
Publications
Showing 1-6 of 20 reviews
- July 29, 20265 out of 5 Stars
We are grateful for and admire Dr. Ferng!
- July 14, 20265 out of 5 Stars
Because this is my first time experiencing this type of health issue I am very pleased and overall grateful to all the staff and doctors who took care of me and provided me a whole new understanding of how intense and undertaking this issue has brought to light the appreciation of all involved in this process. Thank you from the bottom of my heart fir tge caring and patience throughout this journey.
- July 13, 20265 out of 5 Stars
Dr. Ferng appears to be a very nice man. Look forward to meeting him in person.
- July 7, 20265 out of 5 Stars
Dr Ferng (and his team, especially Nurse Alex) SUPER!
- June 15, 20265 out of 5 Stars
Dr. Ferng is an excellent provider, I feel confident in his treatment recommendations for my condition.
- June 10, 20265 out of 5 Stars
Excellent!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.